Evidence Hub

Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc-99m, F-18, I-131, and Lu-177

Oumano M, Wendt R, Botti J, Busse N, Hintenlang D, Leon S, Little K, Martin M et al.

Journal of applied clinical medical physics, 2025

177 participants · 3 citations

Abstract

Abstract Introduction The use of radioactive materials in the United States has been tightly regulated by the Nuclear Regulatory Commission and other entities for many decades. In 2015, however, the Joint Commission began to require hospital‐based nuclear medicine departments to conduct shielding designs and evaluations for radioactive material areas, mirroring established x‐ray practices. NCRP Report No. 147 guides diagnostic medical x‐ray shielding, but obviously cannot be used alone for nuclear medicine applications. The rising demand for theranostic nuclear medicine shielding evaluations particularly necessitates updated focused guidance, the aim of this report. Methods Monte Carlo simulations were conducted using GATE software to analyze the effects of various barriers on the transmission of radioactive emissions. The simulations used point sources of Tc‐99m, F‐18, I‐131, and Lu‐177 and evaluated dose deposition to blocks of tissue using Dose Actors. Different ceiling heights (ranging from 10–16 feet) were also tested for scattering effects. The Archer equation was employed to fit transmission curves and estimate required barrier thicknesses. Results Broad beam transmission factors and Archer fitting parameters are reported for various materials including lead, gypsum, concrete (light weight and normal weight), glass, and steel. A sample shielding calculation is provided for a wall separating Lu‐177 dotatate patients from an adjacent office to maintain public dose…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free